Cullinan Therapeutics, Inc. Common Stock

CGEM us
$14.81
▼ 0.63 (-4.08%)
Volume: 1,715,490 · 2026-09-25

📈 Price Chart

Loading…
RSI (14)

🧭 Style Verdicts

🚀 Momentum 25
  • 21d momentum -35.2%
  • RSI 24 oversold
🎯 Pullback 73
  • RSI 24 near lows
  • Near lower Bollinger band
  • -27.9% vs 20MA
💎 Value 58
  • -36% off 52w high

Scores (0–100) derived from live technical & fundamental metrics. Not investment advice.

📐 Technicals

RSI(14)23.7
MACD-0.808
MA trendMixed
ATR8.88%
21d mom.-35.2%
63d mom.-19.5%
vs 20MA-27.9%
RVOL(20)1.52×
52w low · 6 52w high · 23
-36.1% from 52-week high
20d support 15 · resistance 23

Computed live from daily OHLCV · as of 2026-09-25

🏦 Fundamentals

Market cap$994M
PER—
PBR3.09
PSR—
EPS$-2.78
ROE-55.6%
ROA-49.2%
Dividend yield0.00%
Debt/Equity0.00
EV/EBITDA-4.13
week1M3M6M1YYTD
-29.74% -35.19% -19.51% +8.34% +145.61% +46.34%

Valuation and profitability in USD, latest reported 2026-09-24. Period returns are price-based.

⚖️ AI Bull vs Bear

🐂 Bull
0/10
🐻 Bear
10/10

14d momentum -32.96%, daily vol 5.04%. Cullinan Therapeutics, Inc. Common Stock sits in a bearish regime.

Derived from 14-day momentum and daily volatility on real OHLCV.

🗞 Related News

No recent news.